Clinical Trials
3 trialsNCT06741072 2026-04-21
BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting Solid Organ Transplants
Ohio State University Comprehensive Cancer Center
Phase 1 Suspended
NCT03795389 2021-09-13
Study to Assess PK, Safety and Tolerability in Patients With DM and CKD
DiaMedica Therapeutics Inc
Phase 1 Completed
NCT00097747 2012-12-21
Safety and Pharmacokinetics of Single Intravenous Doses of Peginesatide in Healthy Volunteers
Affymax
Phase 1 Completed